Combination antipsychotic-SSRI tablets for oral use, distributed by pharmaceutical firms to bipolar disorder units, psychiatric hospitals, and global traders. Acquired by healthcare buyers for maintenance therapy in treatment-resistant depression within specialized care facilities.